Retour à l'accueil - Logo OERECA

EA 2608 | Oestrogènes, reproduction, cancer

Accueil > Publications et diffusion scientifique > 2017


2017

Group 6. Modalities and frequency of monitoring of patients with adrenal insufficiency. Patient education. Guignat L, Proust-Lemoine E, Reznik Y, Zenaty D. Ann Endocrinol (Paris). 2017 Dec;78(6):544-558. doi: 10.1016/j.ando.2017.10.009. Epub 2017 Dec 1. Review.

Group 2: Adrenal insufficiency: screening methods and confirmation of diagnosis.
Chanson P, Guignat L, Goichot B, Chabre O, Boustani DS, Reynaud R, Simon D, Tabarin A, Gruson D, Reznik Y, Raffin Sanson ML. Ann Endocrinol (Paris). 2017 Dec;78(6):495-511. doi: 10.1016/j.ando.2017.10.005. Epub 2017 Nov 23. Review.

Group 4: Replacement therapy for adrenal insufficiency.

Castinetti F, Guignat L, Bouvattier C, Samara-Boustani D, Reznik Y. Ann Endocrinol (Paris). 2017 Dec;78(6):525-534. doi: 10.1016/j.ando.2017.10.007. Epub 2017 Nov 21. Review. No abstract available.

Personalization of a compartmental physiological model for an artificial pancreas through integration of patient's state estimation.

Jallon P, Lachal S, Franco C, Charpentier G, Huneker E, Doron M, Franc S, Benhamou PY, Borot S, Guerci B, Hanaire HLN, Jeandidier N, Penfornis A, Renard E, Reznik Y, Schaepelynck P, Simon C. Conf Proc IEEE Eng Med Biol Soc. 2017 Jul;2017:1453-1456. doi: 10.1109/EMBC.2017.8037108.

Shear Wave Elastography in Thyroid Nodules with Indeterminate Cytology: Results of a Prospective Bicentric Study.

Bardet S, Ciappuccini R, Pellot-Barakat C, Monpeyssen H, Michels JJ, Tissier F, Blanchard D, Menegaux F, de Raucourt D, Lefort M, Reznik Y, Rouxel A, Heutte N, Brenac F, Leconte A, Buffet C, Clarisse B, Leenhardt L. Thyroid. 2017 Nov;27(11):1441-1449. doi: 10.1089/thy.2017.0293. 

Vitamin D-Dependent Rickets Type 1B (25-Hydroxylase Deficiency): A Rare Condition or a Misdiagnosed Condition?
Molin A, Wiedemann A, Demers N, Kaufmann M, Do Cao J, Mainard L, Dousset B, Journeau P, Abeguile G, Coudray N, Mittre H, Richard N, Weryha G, Sorlin A, Jones G, Kottler ML, Feillet F. J Bone Miner Res. 2017 Sep;32(9):1893-1899. doi: 10.1002/jbmr.3181. Epub 2017 Jul 13.

Syndecan 1 represses cell growth and FSH responsiveness in human granulosa cells.

Colombe S, Houllier L, Fleurot E, Levallet G, Benhaïm A, Bonnamy PJ, Levallet J.
Reproduction. 2017 Jun;153(6):797-808. doi: 10.1530/REP-17-0074. Epub 2017 Mar 27.

Interactions between oestrogen and 1α,25(OH)2-vitamin D3 signalling and their roles in spermatogenesis and spermatozoa functions.
Zanatta AP, Brouard V, Gautier C, Goncalves R, Bouraïma-Lelong H, Mena Barreto Silva FR, Delalande C.
Basic Clin Androl. 2017 May 8;27:10. doi: 10.1186/s12610-017-0053-z. eCollection 2017.

Calcium pyrophosphate deposition disease revealing a hypersensitivity to vitamin D.
Baudart P, Molin A, Cesini J, Jones G, Kaufmann M, Kottler ML, Marcelli C.
Joint Bone Spine. 2017 May;84(3):349-351. doi: 10.1016/j.jbspin.2016.11.006. Epub 2017 Jan 18.

Hyaluronate synthase-2 overexpression alters estrogen dependence and induces histone deacetylase inhibitor-like effects on ER-driven genes in MCF7 breast tumor cells.
Vanneste M, Hanoux V, Bouakka M, Bonnamy PJ.
Mol Cell Endocrinol. 2017 Mar 15;444:48-58. doi: 10.1016/j.mce.2017.01.046. Epub 2017 Jan 28.

Maternal Nutrition during Pregnancy Affects Testicular and Bone Development, Glucose Metabolism and Response to Overnutrition in Weaned Horses Up to Two Years. Robles M, Gautier C, Mendoza L, Peugnet P, Dubois C, Dahirel M, Lejeune JP, Caudron I, Guenon I, Camous S, Tarrade A, Wimel L, Serteyn D, Bouraima-Lelong H, Chavatte-Palmer P.
PLoS One. 2017 Jan 12;12(1):e0169295. doi: 10.1371/journal.pone.0169295. eCollection 2017.

Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas.
Lasolle H, Cortet C, Castinetti F, Cloix L, Caron P, Delemer B, Desailloud R, Jublanc C, Lebrun-Frenay C, Sadoul JL, Taillandier L, Batisse-Lignier M, Bonnet F, Bourcigaux N, Bresson D, Chabre O, Chanson P, Garcia C, Haissaguerre M, Reznik Y, Borot S, Villa C, Vasiljevic A, Gaillard S, Jouanneau E, Assié G, Raverot G.
Eur J Endocrinol. 2017 Jun;176(6):769-777. doi: 10.1530/EJE-16-0979.

Use of GLP-1 receptor agonists for type 2 diabetes treatment intensification after basal insulin failure.
Joubert M, Reznik Y.
Diabetes Metab. 2017 Apr;43 Suppl 1:2S34-2S38. doi: 10.1016/S1262-3636(17)30071-X.

Glycemic Control During Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Insulin Injections in Type 2 Diabetes: Individual Patient Data Meta-analysis and Meta-regression of Randomized Controlled Trials.
Pickup JC, Reznik Y, Sutton AJ.
Diabetes Care. 2017 May;40(5):715-722. doi: 10.2337/dc16-2201. Review.

Factors associated with improved glycemic control following continuous subcutaneous insulin infusion therapy in patients with type 2 diabetes uncontrolled with bolus-basal insulin regimens: an analysis from the OpT2mise randomized trial.
Metzger M, Castañeda J, Reznik Y, Giorgino F, Conget I, Aronson R, de Portu S, Runzis S, Lee SW, Cohen O.
Diabetes Obes Metab. 2017 Apr 4. doi: 10.1111/dom.12960. [Epub ahead of print]

Impact of a Paper-Based Dynamic Insulin Infusion Protocol on Glycemic Variability, Time in Target, and Hypoglycemic Risk: A Stepped Wedge Trial in Medical Intensive Care Unit Patients.
Clergeau A, Parienti JJ, Reznik Y, Clergeau D, Seguin A, Valette X, du Cheyron D, Joubert M.
Diabetes Technol Ther. 2017 Feb;19(2):115-123. doi: 10.1089/dia.2016.0314.

Cabergoline for Cushing's disease: a large retrospective multicenter study.
Ferriere A, Cortet C, Chanson P, Delemer B, Caron P, Chabre O, Reznik Y, Bertherat J, Rohmer V, Briet C, Raingeard I, Castinetti F, Beckers A, Vroonen L, Maiter D, Cephise-Velayoudom FL, Nunes ML, Haissaguerre M, Tabarin A.
Eur J Endocrinol. 2017 Mar;176(3):305-314. doi: 10.1530/EJE-16-0662. Epub 2016 Dec 22.

Intellectual disability in patients with MODY due to hepatocyte nuclear factor 1B (HNF1B) molecular defects.
Dubois-Laforgue D, Bellanné-Chantelot C, Charles P, Jacquette A, Larger E, Ciangura C, Saint-Martin C, Rastel C, Keren B, Timsit J; Monogenic Diabetes Study Group of the Société Francophone du Diabète (SFD).
Diabetes Metab. 2017 Feb;43(1):89-92. doi: 10.1016/j.diabet.2016.10.003. Epub 2016 Nov 10. No abstract available.

Factors affecting the benefit of insulin dose intensification in people with Type 2 diabetes: an analysis from the OpT2mise randomized trial.
Schütz-Fuhrmann I, Castañeda J, Reznik Y, Aronson R, Conget I, Liabat S, Runzis S, de Portu S, Cohen O.
Diabet Med. 2017 Feb;34(2):291-292. doi: 10.1111/dme.13279. No abstract available.


Télécharger la page

Dernière modification : 2 octobre 2018



Université de Caen Normandie
Laboratoire OERECA
Esplanade de la Paix | CS 14032 | 14032 CAEN cedex 5